Haesook T. Kim

Also affiliated with Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.563Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2024012561

Top 35%

0.563DataRank

Top 35%19 citations

Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng +22 more

Papers

Driven by 20 papers — median percentile 65. Top paper: “Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse”.

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse

Journal of Clinical Investigation(2022)10.1172/jci154334

N/A

3.2DataRank · unranked

139 citations

Grace C. Birch, Guangan Hu, Juliana Vergara Cadavid, Sarah Nikiforow, Joanna Baginska +27 more

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Blood(2020)10.1182/blood.2019004710

N/A

2.8DataRank · unranked

99 citations

Haesook T. Kim, Caitlin Costello, Alex F. Herrera, Frederick L. Locke, Rodrigo Maegawa +20 more

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy

Cell Reports(2021)10.1016/j.celrep.2021.109992

N/A

1.6DataRank · unranked

59 citations

Elham Azizi, Cassandra Burdziak, Vinhkhang N. Nguyen, Christina Ennis, Katie Maurer +17 more

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Blood Advances(2024)10.1182/bloodadvances.2023012120

N/A

1.2DataRank · unranked

46 citations

Haesook T. Kim, H. Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey Cutler +18 more

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract

Blood Advances(2024)10.1182/bloodadvances.2024012556

N/A

0.724DataRank · unranked

23 citations

Ashish Damania, Haesook T. Kim, Chia‐Chi Chang, Areej El‐Jawahri, Steven L. McAfee +20 more

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Blood(2021)10.1182/blood.2021010867

N/A

0.564DataRank · unranked

42 citations

Yi Zhang, Alexandra Savell, Teddy Huang, Nicoletta Cieri, Emily M. Thrash +33 more

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2024012561

Top 35%

0.563DataRank

Top 35%19 citations

Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng +22 more

Donor clonal hematopoiesis and recipient outcomes after transplantation

medRxiv(2021)10.1101/2021.09.25.21263697

N/A

0.425DataRank · unranked

16 citations

Haesook T. Kim, Lin Zhao, H. Moses Murdock, Bryan C. Hambley, Alana F. Ogata +24 more

Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.05.001

N/A

0.345DataRank · unranked

9 citations

Vincent T. Ho, Sarah Nikiforow, Corey Cutler, John Koreth, Roman M. Shapiro +7 more

Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-23-0138

N/A

0.345DataRank · unranked

9 citations

Nicoletta Cieri, Katie Maurer, Marwan Kwok, Haoxiang Lyu, Wesley S. Lu +16 more

Reduced incidence of relapse and graft-versus-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation

Haematologica(2025)10.3324/haematol.2025.287390

N/A

0.104DataRank · unranked

1 citations

Robert J. Soiffer, Corey Cutler, John Koreth, Sarah Nikiforow, Roman M. Shapiro +8 more

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML

Blood Advances(2025)10.1182/bloodadvances.2025018631

N/A

0DataRank · unranked

0 citations

Haesook T. Kim, H. Moses Murdock, Anna Bosch, Kevin M. Panaro, Felicia Lim +20 more

Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease

Journal of Clinical Investigation(2020)10.1172/jci129965

N/A

0DataRank · unranked

86 citations

Anders Theodor Aasebo, Tiago R. Matos, Pei‐Chen Hsieh, Matthew Collin, Christopher P. Elco +20 more

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Blood Advances(2020)10.1182/bloodadvances.2020001956

N/A

0DataRank · unranked

86 citations

Peter Dreger, Jennifer R. Brown, Oscar Lahoud, Toby A. Eyre, Danielle M. Brander +20 more

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Blood(2022)10.1182/blood.2021014520

N/A

0DataRank · unranked

74 citations

Haesook T. Kim, Nathan Denlinger, Pankit Vachhani, Bryan C. Hambley, Bryan Manning +18 more

Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease

Frontiers in Immunology(2022)10.3389/fimmu.2022.954966

N/A

0DataRank · unranked

8 citations

Haesook T. Kim, Peter Stowe, Carol Reynolds, Jerome Ritz, John Koreth +2 more

Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD

Blood Advances(2023)10.1182/bloodadvances.2023009791

N/A

0DataRank · unranked

24 citations

Vincent T. Ho, Eno Inyang, Corey Cutler, John Koreth, Roman M. Shapiro +9 more

Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.029

N/A

0DataRank · unranked

10 citations

P. Connor Johnson, Haesook T. Kim, Alisha Yi, Meghan E. Sise, David E. Leaf +14 more

Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells

Blood Advances(2023)10.1182/bloodadvances.2022009231

N/A

0DataRank · unranked

12 citations

Haesook T. Kim, Heather Garrity, Deborah Liney, Corey Cutler, Joseph H. Antin +10 more

Poor Engraftment After Posttransplant Cyclophosphamide Graft‐Versus‐Host Disease Prophylaxis in Patients With Myelofibrosis

American Journal of Hematology(2025)10.1002/ajh.27741

N/A

0DataRank · unranked

3 citations

Deborah Liney, Kristen Rizza, Corey Cutler, John Koreth, Sarah Nikiforow +10 more

Haesook T. Kim

Indexed papers

Top data-sharing exemplar

Papers